Press release
Particulate Respirators Market - Global Industry Insights and Opportunity Analysis 2025
Particulate respirators are medical devices, which helps to protect one from harmful particles present in the air or dust or harmful fumes. Such harmful dust usually spread through severe acute respiratory syndrome (SARS). SARS is a respiratory syndrome commonly spread among symptomatic individuals, by person-to-person contact, or when the person sneezes or coughs, thereby infecting the nearby surfaces or through airborne transmission. Being a communicable disease, healthcare professionals and medical transport workers are at high risk to such disease as they frequently come in contact with patients suffering from SARS. Hence, Center for Disease Control and Prevention (CDC) has issued interim infection control recommendations for those high risky healthcare centers and facilities. Particulate respirators have proved to be excellent personal protector equipment in order to reduce the risk of inhaling harmful airborne particles. Particulate respirators which has the capability of filtering out 95% of airborne particles are given a 95 rating according to CDC. Likewise, respirators with 99% capability of filtering particles are given a 99 rating and so on.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/59
Government initiatives are helping spread awareness among SARS affected victims and helps in fostering market growth
Increasing prevalence of SARS is one of the major drivers impacting the particulate respirators market growth. Moreover, low cost of the product, increasing R&D activities and government initiatives undertaken in order to secure the healthcare professionals from such airborne transmission are some of the factors fueling the demand for particulate respirators. CDC is working with federal agencies, healthcare organizations and local health departments in order to spread awareness among healthcare workers for rapid recognition of person-to-person transmission of SARS. However, lack of proper awareness among people pertaining to the various types of particulate respirators available is hindering the market growth
Disposable respirators are less costly and easy to discard if damaged
On the basis of product, particulate respirators market is segmented into disposable or filtering facepiece respirators, reusable or elastomeric respirators and powered air-purifying respirators. Disposable respirators are for single-use as it gets damaged physically due to excessive resistance and sorbent exhaustion. Reusable respirators are cleaned and reused. However, the filter cartridges are disposed when they become unsuitable for use. Powered air-purifying respirators are usually attached with a battery powered blower which filters the harmful air.
Based on design, particulate respirators are of two types, half face respirators and full face respirators. Particulate respirators are used in hospital settings and also for military, laboratory and other purposes. On the basis of geography, the market is divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Greater awareness levels in North America is enhancing the market growth
North America is one of the high revenue generating market for particulate respirators owing to their growing awareness levels regarding the usage of particulate respirators and increasing R&D activities in this region. Asia Pacific is considered as a lucrative market for growing opportunities of particulate respirators primarily due to the rising prevalence of respiratory disorders in countries like India. The major players are expected to find huge growth opportunities in such countries owing to the rising airborne transmitted diseases.
Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/particulate-respirators-market-59
3M is one of the leading players of the market based on the performance and sales
Some of the key players for particulate respirators market include 3M Company, The Gerson Company, Drägerwerk AG & Co. KGaA, Honeywell International Inc., MOLDEX and Northern Safety Co., Inc. among others. New product launch is one of the key initiatives undertaken by these companies. For instance, in 2015, 3M launched organic vapor respirator cartridges, which has 3M Service Life Indicator technology that helps to direct the user for an appropriate time to change the cartridges.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Particulate Respirators Market - Global Industry Insights and Opportunity Analysis 2025 here
News-ID: 773096 • Views: …
More Releases from Medical Devices Report By CMI
Increasing demand for minimally invasive surgeries to treat various medical cond …
According to a study published in the New England Journal of Medicine, 2016, the number of patients opting for endovascular aneurysm repair has increased significantly during 2005–2012. For instance, in 2005, the percentage of patients in the U.S. suffering from aneurysm opting for EVAR was around 50%, which increased to 75.4% in 2012. A similar pattern was observed in England. Increasing consumer inclination towards this revolutionary procedure is attributed to…
Insulin Delivery Devices Market to Surpass US$ 17.83 Billion by 2025
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin…
U.S. Hospital Beds Market to Surpass US$ 1.4 Billion Threshold by 2025 Initiativ …
U.S. Hospital Beds Market Driven By Increasing Chronic Diseases Needs Longer Hospital Stay
Hospitals beds are used for proper patient care in various settings, such as elderly care facilities, home care settings, ambulatory surgical centers, and hospitals. Hospital beds are comfortable than household beds as they are versatile in terms of inclination and reclined as per the patient condition. Household beds are difficult to clean and maintain hygiene for longer period…
Protein Assays Market to Surge to US$ 3.65 Billion by 2025
Protein Assays Market: Insights
Protein assays are used to determine the concentration of solubilized protein. Various biochemical methods are available for quantification, isolation, and analysis of proteins. The selection among available protein assays is based on factors such as its chemical compatibility with buffer components of the samples to be assayed. The recent past has witnessed an increasing inclination of end users towards high quality and safety for drugs and its…
More Releases for SARS
Existing Drugs May Inhibit SARS-CoV-2 Virus
The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally. The search for effective treatments against the disease are ongoing, and one hurdle is that SARS-CoV-2, the virus that causes COVID-19, has a number of tricks up its molecular sleeve when it comes to infecting people.
In a recent study published in Nature Communications Biology, researchers from…
Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales Market Report …
In this report, the global Severe Acute Respiratory Syndrome(SARS) Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Severe Acute Respiratory Syndrome(SARS) Therapeutics for these…
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape.
Severe acute respiratory syndrome (SARS) is a serious, potentially…
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 Pharmaceutical Re …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017”. Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family.
Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305521
Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea and vomiting. Risk factors include gene variation in the…
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insigh …
Market Research Hub, “Severe Acute Respiratory Syndrome Coronavirus Infection Pipeline Insights”, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection by development stage, therapy type, route of administration…
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape.
Severe acute respiratory syndrome (SARS) is a serious, potentially…
